Pharmafile Logo
Pharmafocus logo
Advanced Search

flu

Showing 15 posts of 41 posts found.

Roche’s flu drug speeds up recovery in Phase III trial

October 4, 2018
Research and Development Roche, drug, flu, pharma, recovery

Swiss multinational Roche’s flu drug baloxavir marboxil significantly sped up recovery time in comparison with placebo, in people at high …

News
injection

More effective flu vaccine could prevent hundreds of elderly deaths across UK this winter

September 12, 2018
Medical Communications, Research and Development NHS, Vaccine, flu, influenza, pharma

Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …

News

Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines

August 16, 2018
Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma

Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …

News

Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?

July 17, 2018
Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma

Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …

News
flumist

CDC U-turns previous decision on AZ’s flu vaccine

February 22, 2018
Sales and Marketing AstraZeneca, Vaccine, biotech, drugs, flu, influenza, pharma, pharmaceutical

The US Centers for Disease Control and Prevention (CDC) has now recommended AstraZeneca’s FluMist as an option for doctors for …

News
flu_virus

Low flu vaccine efficacy may be due to previous immune history, study finds

February 20, 2018
Manufacturing and Production, Research and Development H3N2, Vaccine, flu, flue vaccine, influenza, pharma

The sometimes poor efficacy of influenza vaccines may be due to poor immune response and a patient’s wider immune history, …

News
flu

New flu med can destroy influenza virus in one day

February 13, 2018
Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical

Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …

News
influenza_dan_higgins_douglas_jordan_uscdcp

New vaccine provides universal protection against influenza A, study finds

January 24, 2018
Research and Development Georgia State University, Vaccine, flu, influenza, pharma

Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …

News
flu

Universal flu vaccine receives Google’s financial backing

January 15, 2018
Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical

Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …

News
seqirus_08-11-17_full-42_003_web

Seqirus announces £40m UK fill-and-finish flu vaccine facility

November 9, 2017
Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus

Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …

News
child_flu

Collaboration brings forward potential broad flu cure

October 2, 2017
Research and Development, Sales and Marketing biotech, drugs, flu, influenza, pharma, pharmaceutical

A joint research effort between The Scripps Research Institute and Janssen has seen the development of a peptide that could …

News
virus-1812092_960_720

Newly adopted flu vaccine could save 1,700 lives

September 12, 2017
Research and Development, Sales and Marketing biotech, drugs, flu, fluad, pharma, pharmaceutical, seqirus

The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …

News
microneedle-patch4004

Revolutionary patch could offer alternative to flu injections

June 28, 2017
Research and Development flu, flu vaccine, patch delivery

A patch developed by a team at the Georgia Institute of Technology alongside Emory University has found that it is …

News
sanofi_pasteur_scientist

MHRA approves Sanofi Pasteur MSD’s four-strain influenza vaccine for UK use

July 25, 2016
Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi pasteur msd, UK, Vaccine, flu, influenza

Sanofi Pasteur MSD has announced the approval of the latest addition to its family of influenza vaccines in the UK: …

News
azhqlondonweb

AstraZeneca set to lose out on $80 million after US turns down flu vaccine

June 23, 2016
Sales and Marketing AstraZeneca, CDC, flu, flu vaccine

AstraZeneca has confirmed that its influenza vaccine, FluMist Quadrivalent, will not be used in the US during the 2016-17 flu …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026